Mefenorex
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| 3-chloro-N-(1-methyl-2-phenylethyl)propan-1-amine | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 17243-57-1 |
| ATC code | A08AA09 |
| PubChem | CID 21777 |
| ChemSpider | 20467 |
| UNII | K98M4N387W |
| KEGG | D07891 |
| Chemical data | |
| Formula | C12H18ClN |
| Mol. mass | 211.731 |
| SMILES | eMolecules & PubChem |
|
|
| |
Mefenorex (Rondimen, Pondinil, Anexate) is a stimulant drug which was used as an appetite suppressant. It is an amphetamine derivative which was developed in the 1970s and used for the treatment of obesity.[1][2] Mefenorex produces amphetamine as a metabolite,[3] and has been withdrawn in many countries despite having only mild stimulant effects and relatively little abuse potential.[4]
[edit] References
- ^ Vincendeau MJ. A new regulator of appetite: mefenorex. (French). Bordeaux Medical. 1970 Jul-Aug;3(7):1951-3.
- ^ Beyer G, Huth K, Muller GM, Niemoller H, Raisp I, Vorberg G. The treatment of obesity with the appetite curbing agent Mefenorex. (German). Die Medizinische Welt. 1980 Feb;31(8):306-9.
- ^ Rendic S, Slavica M, Medic-Saric M. Urinary excretion and metabolism of orally administered mefenorex. European Journal of Drug Metabolism and Pharmacokinetics. 1994 Apr-Jun;19(2):107-17.
- ^ Engel J, Kristen G, Schaefer A, von Schlichtegroll A. Mefenorex (Rondimen). Drug and Alcohol Dependence. 1986 Jun;17(2-3):229-34.
|
|
|
|
| This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |

